API 0.74% $1.35 australian pharmaceutical industries limited

Highly undervalued, page-20

  1. 287 Posts.
    Yep think people seem to be missing this.

    NPAT $51.7M FY16, so looking like $53.6M or so in FY17, as opposed to minimum NPAT of $56.2M originally forecast.

    The SP this time last year was around $1.90. Making more profit, just didnt hit expectations. SP now at $1.55 which I just bought in at. MC is now around $760M or so compared to $868M last year? Still doing well against peers, so think this is pretty cheap atm
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.